Table 1.
Clinical evaluation of candidiasis lesion on the dorsal tongue as a % of affected surface area with respect to the total surface area of the tongue.
| Group | 5 Days % (SD) | 10 Days % (SD) |
|---|---|---|
| Control | 4.88 (0.41) | 3.90 (0.53) ♦ |
| Placebo water | 4.93 (0.09) | 3.95 (0.80) ♦ |
| Placebo orabase | 4.96 (0.79) | 3.90 (0.13) ♦ |
| Placebo chitosan | 4.72 (0.14) | 3.82 (0.98) ♦ |
| Nystatin + water | 3.87 (0.62) ▪ | 3.26 (0.23) ♦ ▪ |
| Nystatin + orabase | 1.20 (0.42) ▪ ♥ | 0.69 (0.42) ♦ ▪ ♥ |
| Nystatin + chitosan | 0.67 (0.25) ▪ ♥ | 0.14 (0.12) ♦ ▪ ♥ ♣ |
♦ Significant differences between groups treated for 5 or 10 days.
▪ Significant differences between groups treated with nystatin and control/placebo groups.
♥ Significant differences between groups treated with nystatin + orabase or nystatin + chitosan and groups treated with nystatin + water.
♣ Significant differences between groups treated with nystatin + chitosan and groups treated with nystatin + orabase.